Research programme: P 014 - NB Health Laboratory
Alternative Names: P-014 - NB Health LaboratoryLatest Information Update: 07 Oct 2021
At a glance
- Originator NB Health Laboratory
- Class Anti-inflammatories; Antivirals; Monoclonal antibodies
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Gastrointestinal disorders; Viral infections
Most Recent Events
- 28 Sep 2021 P 014 - NB Health Laboratory is available for licensing as of 28 Sep 2021. https://nbhl.co.jp/nbhlhpwordpress/partnering.html
- 28 Sep 2021 Early research in Gastrointestinal disorders in Japan (Parenteral) before September 2021 (NB Health Laboratory pipeline, September 2021)
- 28 Sep 2021 Early research in Viral infections in Japan (Parenteral) before September 2021 (NB Health Laboratory pipeline, September 2021)